Group 1 - The implementation of drug traceability codes will reshape the management ecosystem of medical insurance drugs in China, with a focus on preventing fraud and ensuring compliance [2][4][9] - Starting from July 1, 2025, new drug purchases must be scanned for traceability codes to settle medical insurance claims, while existing unmarked drugs will be managed under a transitional "unmarked library" [3][4] - By January 1, 2026, all medical institutions must fully collect traceability codes, establishing a complete drug traceability loop [3] Group 2 - The unique design of traceability codes, which includes features like uniqueness and detailed management, is crucial for regulatory effectiveness [2] - As of March 20, 2025, over 350 pharmaceutical production and distribution companies have connected to the traceability platform, with nearly 8,000 companies inquiring about the upload and query process [2] - The traceability code system is expected to reduce management costs by 20% and improve operational efficiency by over 30% for companies integrating with the national traceability platform [7] Group 3 - Consumers can verify drug sales and protect their rights using traceability codes, which should only have one sales record [6] - The current legal framework provides strong protections for consumers against fraud, allowing for significant compensation in cases of selling counterfeit drugs [7] - The comprehensive application of traceability codes is seen as a new starting point for the digital transformation of the pharmaceutical industry [9]
今起,买卖药必扫!医保结算步入全面追溯码时代
2 1 Shi Ji Jing Ji Bao Dao·2025-07-01 04:53